Bavarian Nordic
Tracked across 3 events · 34 articles · First seen Apr 07, 2026 · Last active Aug 07, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Bavarian Nordic is repurchasing its own shares to adjust its capital structure, which is generally seen as a positive signal to the market.
Jun 02, 2026 · 22 articles
Regulatory
Impact: Bavarian Nordic is the vaccine developer and manufacturer; the submission in Brazil expands its market reach beyond travel vaccines into endemic regions, potentially boosting sales.
Jul 13, 2026 · 6 articles
Regulatory
Impact: Bavarian Nordic is the vaccine developer and manufacturer; the EU approval for children expands its market and strengthens its position in mpox/smallpox preparedness, likely boosting revenue prospects.
Aug 07, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Bavarian Nordic live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard